Adherence to Barcelona Clinic Liver Cancer guidelines in field practice

Results of Progetto Epatocarcinoma Campania

Maria Guarino, Raffaella Tortora, Giorgio de Stefano, Carmine Coppola, Filomena Morisco, Angelo Salomone Megna, Francesco Izzo, Gerardo Nardone, Guido Piai, Luigi Elio Adinolfi, Giuseppe D'Adamo, Giovanni Battista Gaeta, Vincenzo Messina, Giampiero Francica, Vincenzo De Girolamo, Nicola Coppola, Marcello Persico, Giovan Giuseppe Di Costanzo

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background and Aim: The Barcelona Clinic Liver Cancer (BCLC) algorithm is the standard system for clinical management of hepatocellular carcinoma (HCC). Data on adherence to this therapeutic paradigm are scarce. This field practice study aimed to provide a description of HCC cirrhotic patients in Southern Italy, to evaluate the adherence to BCLC guidelines and its impact on patients' survival. Methods: We analyzed the region-wide Italian database of Progetto Epatocarcinoma Campania, which includes data of HCC cirrhotic patients, prospectively collected from January 2013 to December 2015 in 16 regional centers. Results: Overall, 1008 HCC patients were enrolled: 70.6% patients received therapies recommended by BCLC algorithm, while 29.4% underwent different treatments. Among patients who were treated in adherence to guidelines, a higher rate of diagnosis on surveillance programs, better liver function, lower rate of alpha-fetoprotein > 200 ng/mL, more early-stage and monofocal HCC, lower frequency of nodules > 5 cm, portal vein thrombosis and metastases were observed. The overall survival was evaluated according to HCC stage and no differences between groups and patients managed differently were found. The multivariate analysis showed that non-adherence to treatment guidelines was independently associated to the BCLC stage B, Child-Pugh classes B and C, and the presence of neoplastic thrombosis and metastases. Conclusion: Adherence to BCLC algorithm in field practice was high in early and end-stage HCC patients, but it was poor in intermediate and advanced patients.

Original languageEnglish
JournalJournal of Gastroenterology and Hepatology (Australia)
DOIs
Publication statusPublished - Jan 1 2018

Fingerprint

Liver Neoplasms
Guidelines
Hepatocellular Carcinoma
Thrombosis
Neoplasm Metastasis
Guideline Adherence
Survival
alpha-Fetoproteins
Therapeutics
Portal Vein
Italy
Multivariate Analysis
Databases
Liver

Keywords

  • Adherence
  • BCLC
  • Guidelines
  • Hepatocellular carcinoma
  • Treatment

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this

Adherence to Barcelona Clinic Liver Cancer guidelines in field practice : Results of Progetto Epatocarcinoma Campania. / Guarino, Maria; Tortora, Raffaella; de Stefano, Giorgio; Coppola, Carmine; Morisco, Filomena; Salomone Megna, Angelo; Izzo, Francesco; Nardone, Gerardo; Piai, Guido; Adinolfi, Luigi Elio; D'Adamo, Giuseppe; Gaeta, Giovanni Battista; Messina, Vincenzo; Francica, Giampiero; De Girolamo, Vincenzo; Coppola, Nicola; Persico, Marcello; Di Costanzo, Giovan Giuseppe.

In: Journal of Gastroenterology and Hepatology (Australia), 01.01.2018.

Research output: Contribution to journalArticle

Guarino, M, Tortora, R, de Stefano, G, Coppola, C, Morisco, F, Salomone Megna, A, Izzo, F, Nardone, G, Piai, G, Adinolfi, LE, D'Adamo, G, Gaeta, GB, Messina, V, Francica, G, De Girolamo, V, Coppola, N, Persico, M & Di Costanzo, GG 2018, 'Adherence to Barcelona Clinic Liver Cancer guidelines in field practice: Results of Progetto Epatocarcinoma Campania', Journal of Gastroenterology and Hepatology (Australia). https://doi.org/10.1111/jgh.14013
Guarino, Maria ; Tortora, Raffaella ; de Stefano, Giorgio ; Coppola, Carmine ; Morisco, Filomena ; Salomone Megna, Angelo ; Izzo, Francesco ; Nardone, Gerardo ; Piai, Guido ; Adinolfi, Luigi Elio ; D'Adamo, Giuseppe ; Gaeta, Giovanni Battista ; Messina, Vincenzo ; Francica, Giampiero ; De Girolamo, Vincenzo ; Coppola, Nicola ; Persico, Marcello ; Di Costanzo, Giovan Giuseppe. / Adherence to Barcelona Clinic Liver Cancer guidelines in field practice : Results of Progetto Epatocarcinoma Campania. In: Journal of Gastroenterology and Hepatology (Australia). 2018.
@article{081980ee6b864aae84ba4492e0e6f0ae,
title = "Adherence to Barcelona Clinic Liver Cancer guidelines in field practice: Results of Progetto Epatocarcinoma Campania",
abstract = "Background and Aim: The Barcelona Clinic Liver Cancer (BCLC) algorithm is the standard system for clinical management of hepatocellular carcinoma (HCC). Data on adherence to this therapeutic paradigm are scarce. This field practice study aimed to provide a description of HCC cirrhotic patients in Southern Italy, to evaluate the adherence to BCLC guidelines and its impact on patients' survival. Methods: We analyzed the region-wide Italian database of Progetto Epatocarcinoma Campania, which includes data of HCC cirrhotic patients, prospectively collected from January 2013 to December 2015 in 16 regional centers. Results: Overall, 1008 HCC patients were enrolled: 70.6{\%} patients received therapies recommended by BCLC algorithm, while 29.4{\%} underwent different treatments. Among patients who were treated in adherence to guidelines, a higher rate of diagnosis on surveillance programs, better liver function, lower rate of alpha-fetoprotein > 200 ng/mL, more early-stage and monofocal HCC, lower frequency of nodules > 5 cm, portal vein thrombosis and metastases were observed. The overall survival was evaluated according to HCC stage and no differences between groups and patients managed differently were found. The multivariate analysis showed that non-adherence to treatment guidelines was independently associated to the BCLC stage B, Child-Pugh classes B and C, and the presence of neoplastic thrombosis and metastases. Conclusion: Adherence to BCLC algorithm in field practice was high in early and end-stage HCC patients, but it was poor in intermediate and advanced patients.",
keywords = "Adherence, BCLC, Guidelines, Hepatocellular carcinoma, Treatment",
author = "Maria Guarino and Raffaella Tortora and {de Stefano}, Giorgio and Carmine Coppola and Filomena Morisco and {Salomone Megna}, Angelo and Francesco Izzo and Gerardo Nardone and Guido Piai and Adinolfi, {Luigi Elio} and Giuseppe D'Adamo and Gaeta, {Giovanni Battista} and Vincenzo Messina and Giampiero Francica and {De Girolamo}, Vincenzo and Nicola Coppola and Marcello Persico and {Di Costanzo}, {Giovan Giuseppe}",
year = "2018",
month = "1",
day = "1",
doi = "10.1111/jgh.14013",
language = "English",
journal = "Journal of Gastroenterology and Hepatology (Australia)",
issn = "0815-9319",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Adherence to Barcelona Clinic Liver Cancer guidelines in field practice

T2 - Results of Progetto Epatocarcinoma Campania

AU - Guarino, Maria

AU - Tortora, Raffaella

AU - de Stefano, Giorgio

AU - Coppola, Carmine

AU - Morisco, Filomena

AU - Salomone Megna, Angelo

AU - Izzo, Francesco

AU - Nardone, Gerardo

AU - Piai, Guido

AU - Adinolfi, Luigi Elio

AU - D'Adamo, Giuseppe

AU - Gaeta, Giovanni Battista

AU - Messina, Vincenzo

AU - Francica, Giampiero

AU - De Girolamo, Vincenzo

AU - Coppola, Nicola

AU - Persico, Marcello

AU - Di Costanzo, Giovan Giuseppe

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Background and Aim: The Barcelona Clinic Liver Cancer (BCLC) algorithm is the standard system for clinical management of hepatocellular carcinoma (HCC). Data on adherence to this therapeutic paradigm are scarce. This field practice study aimed to provide a description of HCC cirrhotic patients in Southern Italy, to evaluate the adherence to BCLC guidelines and its impact on patients' survival. Methods: We analyzed the region-wide Italian database of Progetto Epatocarcinoma Campania, which includes data of HCC cirrhotic patients, prospectively collected from January 2013 to December 2015 in 16 regional centers. Results: Overall, 1008 HCC patients were enrolled: 70.6% patients received therapies recommended by BCLC algorithm, while 29.4% underwent different treatments. Among patients who were treated in adherence to guidelines, a higher rate of diagnosis on surveillance programs, better liver function, lower rate of alpha-fetoprotein > 200 ng/mL, more early-stage and monofocal HCC, lower frequency of nodules > 5 cm, portal vein thrombosis and metastases were observed. The overall survival was evaluated according to HCC stage and no differences between groups and patients managed differently were found. The multivariate analysis showed that non-adherence to treatment guidelines was independently associated to the BCLC stage B, Child-Pugh classes B and C, and the presence of neoplastic thrombosis and metastases. Conclusion: Adherence to BCLC algorithm in field practice was high in early and end-stage HCC patients, but it was poor in intermediate and advanced patients.

AB - Background and Aim: The Barcelona Clinic Liver Cancer (BCLC) algorithm is the standard system for clinical management of hepatocellular carcinoma (HCC). Data on adherence to this therapeutic paradigm are scarce. This field practice study aimed to provide a description of HCC cirrhotic patients in Southern Italy, to evaluate the adherence to BCLC guidelines and its impact on patients' survival. Methods: We analyzed the region-wide Italian database of Progetto Epatocarcinoma Campania, which includes data of HCC cirrhotic patients, prospectively collected from January 2013 to December 2015 in 16 regional centers. Results: Overall, 1008 HCC patients were enrolled: 70.6% patients received therapies recommended by BCLC algorithm, while 29.4% underwent different treatments. Among patients who were treated in adherence to guidelines, a higher rate of diagnosis on surveillance programs, better liver function, lower rate of alpha-fetoprotein > 200 ng/mL, more early-stage and monofocal HCC, lower frequency of nodules > 5 cm, portal vein thrombosis and metastases were observed. The overall survival was evaluated according to HCC stage and no differences between groups and patients managed differently were found. The multivariate analysis showed that non-adherence to treatment guidelines was independently associated to the BCLC stage B, Child-Pugh classes B and C, and the presence of neoplastic thrombosis and metastases. Conclusion: Adherence to BCLC algorithm in field practice was high in early and end-stage HCC patients, but it was poor in intermediate and advanced patients.

KW - Adherence

KW - BCLC

KW - Guidelines

KW - Hepatocellular carcinoma

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=85041688956&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041688956&partnerID=8YFLogxK

U2 - 10.1111/jgh.14013

DO - 10.1111/jgh.14013

M3 - Article

JO - Journal of Gastroenterology and Hepatology (Australia)

JF - Journal of Gastroenterology and Hepatology (Australia)

SN - 0815-9319

ER -